Plecanatide

CAS 467426-54-6

About the API

Trade name(s) Trulance
Molecular Formula C65H104N18O26S4
Molecular Weight 1681.89 g
Therapeutic category Alimentary Tract, Metabol
Available formulations Oral Solid

General Information

Plecanatide is a drug approved in January 2017 by the FDA for the treatment of chronic idiopathic constipation (CIC). It should not be used in children less than six years of age, and should be avoided in patients six years to 18 years of age.

Plecanatide stimulates intestinal fluid secretions in the gastrointestinal tract to support regular bowel function.